Infectious diseases pose a significant public health burden across emerging markets, resulting in growing reliance on antibiotic therapies. This is where antibiotics like macrolides and aminoglycosides come in.
In recent decades, thanks to the continuous discovery and development of antibiotics, the incidence and mortality rates of diseases caused by bacterial infections have fallen significantly.